Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 29Breast Carcinoma In Situ 4Carcinoma, Intraductal, Noninfiltrating 3Endometrial Neoplasms 2Carcinoma, Ductal, Breast 2Breast Neoplasms, Male 2Sleep Wake Disorders 1Paget's Disease, Mammary 1Gliosarcoma 1Glioblastoma 1Fatigue 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Lobular 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Tamoxifen 2Letrozole 2Brachytherapy 2Radiotherapy, Conformal 1Pharmacogenomic Testing 1Medroxyprogesterone 1Magnetic Resonance Spectroscopy 1Estrogens, Conjugated (USP) 1Docetaxel 1Celecoxib 1Capecitabine 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Ductal, Breast × Tamoxifen × Clear all
NCT00433589 2022-11-17

MINDACT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
6,600 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00004205 2017-12-12

BIG 1-98

ETOP IBCSG Partners Foundation

Phase 3 Completed
8,028 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡